The FDA announced a nationwide recall of Hudson RCI Neonatal/Infant Heated Wire Breathing Circuits, manufactured by Medline/Teleflex, due to a risk of melting, smoke and thermal damage at the humidifier connector, on Aug. 6. The circuits are used in neonatal intensive care units to deliver warm, humidified air to premature

The Department of Health and Human Services’ Administration for Children and Families proposed major reforms to the federal Head Start program aimed at expanding access and giving parents greater control over their children’s early education, on Aug. 6. Head Start serves more than 1 million low-income children annually with comprehensive

The Food and Drug Administration approved the first drug to treat the complete spectrum of narcolepsy type 1 symptoms — including cataplexy, the sudden loss of muscle tone triggered by emotion — the agency announced Aug. 5. An estimated 135,000 to 200,000 Americans have narcolepsy type 1. Previous treatments addressed

The Centers for Medicare and Medicaid Services issued its Fiscal Year 2027 Hospital Inpatient Prospective Payment System final rule on July 31. The rule updates Medicare payment rates for thousands of acute care hospitals and long-term care facilities that serve roughly 65 million Medicare beneficiaries. The annual IPPS rule determines

The Food and Drug Administration approved the first single medication to address the full spectrum of Narcolepsy Type 1 symptoms on Aug. 5. The approval could transform treatment for the estimated 200,000 Americans living with the chronic neurological condition. The drug treats excessive daytime sleepiness, cataplexy and disrupted nighttime sleep,

The Department of Health and Human Services unveiled proposed structural reforms to Head Start, the nation’s largest federal early childhood education program, on Aug. 6. The proposals include expanded access provisions and enhanced parental oversight of program content. The changes would affect approximately 800,000 children nationwide who participate in Head

The Food and Drug Administration issued a recall alert for Hudson RCI neonatal and infant heated wire breathing circuits on Aug. 6. A heated wire connector in the devices may melt and generate smoke, posing fire and burn risks to critically ill newborns in hospital settings. The devices are used

The Food and Drug Administration approved the first engineered virus-based immunotherapy for patients with treatment-resistant advanced melanoma on Aug. 6. The drug opens a new class of cancer treatment for one of the deadliest forms of the disease. The approval targets patients who have exhausted other available therapies, a population

The Centers for Medicare and Medicaid Services released a new toolkit to help state Medicaid programs protect children with autism and strengthen oversight of Applied Behavior Analysis therapy services on Aug. 4, addressing a rapidly growing area of documented billing fraud. ABA therapy for autism has grown into a multibillion-dollar

The National Institutes of Health announced funding for an international research collaboration cataloguing human cancer models derived from thousands of patient donors across 25 tumor types on Aug. 5, creating a standardized resource to accelerate precision cancer drug development. The comprehensive catalog will serve as a shared resource for precision

Fresenius Kabi issued a nationwide voluntary recall of Morphine Sulfate Injection USP after discovering a labeling mix-up on the injectable opioid product, creating what the FDA identified as a significant risk of life-threatening dosing errors in hospitals, on Aug. 5. The recall affects the company’s Simplist brand of morphine injection

The Department of Health and Human Services decertified a Kentucky organ procurement organization on Aug. 5, stripping it of federal authority to recover and allocate donated organs after it failed to meet federal performance standards. Federal decertification of an organ procurement organization is a rare and severe enforcement action with

The Food and Drug Administration approved the first drug to address the complete symptom profile of Narcolepsy Type 1, a breakthrough for an estimated 200,000 Americans living with the chronic neurological disorder, on Aug. 5. The approval marks the first time a single FDA-sanctioned medication can treat both excessive daytime

The Centers for Medicare and Medicaid Services on Aug. 4 released a toolkit to help states protect children with autism from inappropriate Applied Behavior Analysis treatment and strengthen Medicaid program integrity for one of the fastest-growing service categories in the program. ABA therapy has been the subject of growing bipartisan

The Centers for Medicare and Medicaid Services on July 31 published the final rule updating Medicare inpatient and long-term care hospital payment policies and rates for fiscal year 2027, governing reimbursement for every Medicare-participating hospital in the United States. The annual inpatient payment rule is among the most closely tracked